AXSM 8-K 2026-08-10

Axsome Therapeutics, Inc. (AXSM) 8-K dated 2026-08-10 — accession 0001193125-26-341206. This URL is the filing, not the AXSM hub.

Axsome Therapeutics, Inc. (AXSM) is a biotechnology company listed on US.

Axsome Therapeutics, Inc. filed a 8-K on 2026-08-10. Accession 0001193125-26-341206.

Cached items: 2.02, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.

Not investment advice. The AXSM SEC hub lists recent forms. The stock page is the research view.